Dr Pepper Snapple Group, Inc. — Form 10-Q Summary
Filing and period: The supplied filing is for Dr Pepper Snapple Group, Inc., for the quarter ended September 30, 2015—not a filing under the name Keurig Dr Pepper Inc. It reports unaudited results for the three and nine months ended September 30, 2015, compared with the same 2014 periods. Amounts are in millions unless stated otherwise.
Business context and results
The company operated three beverage segments: Beverage Concentrates, Packaged Beverages, and Latin America Beverages. Third-quarter volume (BCS) increased 2%; U.S. and Canada volume rose 1%, while Mexico and Caribbean volume rose 8%.
- Third quarter: Net sales were $1,630, up 3%; gross profit was $957, up 3%; operating income was $337, up 7%; and net income was $202, up 7%. Diluted EPS increased 9% to $1.05.
- Nine months: Net sales were $4,736, up 3%; gross profit was $2,787, up 2%; operating income was $976, up 6%; and net income was $579, up 5%. Diluted EPS rose to $3.00 from $2.79.
- Margins: Third-quarter gross margin improved to 58.7% from 58.4%; nine-month gross margin declined to 58.8% from 59.3%. Operating margin increased to 20.7% from 20.0% for the quarter and 20.6% from 20.0% year to date.
- Cash flow: Nine-month operating cash flow was $723, versus $769 in 2014. Capital expenditures were $71; operating cash flow less capital expenditures was $652. Investing activities used $95, and financing activities used $648.
- Liquidity and debt: Cash was $207 at September 30, 2015, versus $237 at year-end 2014. Current assets were $1,222 and current liabilities $1,589. Debt obligations, including current maturities and capital leases, totaled $2,635; $500 of senior notes were due in January 2016. The company had no commercial paper outstanding and reported $499 available under its $500 revolver, subject to facility terms.
- Shareholder returns: Nine-month dividends paid were $264 and share repurchases were $404. Dividends declared were $1.44 per share; $768 remained under the repurchase authorization at quarter-end.
Changes and segment performance
- Third-quarter sales growth reflected higher concentrate case sales, pricing and mix, partly offset by $39 of unfavorable currency translation. Nine-month sales growth was driven by mix and a 2% increase in concentrate case sales, partly offset by $86 of unfavorable currency translation.
- Packaged Beverages led reported growth: third-quarter sales rose 5% to $1,193 and segment operating profit (SOP) rose 14% to $194; nine-month sales rose 4% to $3,434 and SOP rose 10% to $525.
- Beverage Concentrates third-quarter sales rose 1% to $308 and SOP rose 2% to $204. Latin America Beverages sales fell 10% to $129 in the quarter, largely due to currency translation, while SOP increased 9% to $24. Year-to-date Latin America sales declined 6% to $379 while SOP rose 15% to $68.
- For the first nine months, commodity-derivative mark-to-market results were less favorable: $11 in unrealized losses compared with $15 in unrealized gains in 2014. Lower commodity costs and productivity helped, while product, package and segment mix and currency weighed on gross margin.
Outlook, risks and unusual items
- Management expected 2015 capital expenditures, net of disposal proceeds, to be approximately 3% of net sales, funded from operating cash flow. It stated operating cash flow should cover anticipated obligations for the next 12 months.
- The company intended to issue senior notes to refinance the $500 of 2.90% notes due January 15, 2016. It reported compliance with applicable financial covenants.
- Key exposures include foreign exchange, commodity prices, interest rates, seasonality, and customer and supplier conditions. A 10% currency move was estimated to affect annual operating income by approximately $23; a 10% move in unhedged commodity prices was estimated to affect operating income by approximately $1 for the remainder of 2015.
- Unusual items included a pension settlement charge in third-quarter SG&A and $20 invested in BA Sports Nutrition, LLC for an 11.7% equity-method interest, plus a $15 cost-method investment in Bai Brands, LLC earlier in 2015.
- The company said pending legal matters were not expected to materially adversely affect results, financial condition or liquidity. A New Jersey Superfund site investigation remained unresolved; costs were not reasonably estimable, and approximately $850,000 had been paid through September 30, 2015. Management reported no material change to previously disclosed risk factors.
Important facts for investors to verify
- Confirm the issuer identity: this text is a 2015 Dr Pepper Snapple Group filing, despite the request identifying Keurig Dr Pepper Inc.
- Review refinancing progress and terms for the $500 million 2016 notes, along with available revolver capacity and covenant compliance.
- Assess whether operating cash flow, working capital and shareholder distributions remain sustainable as debt maturities approach.
- Track segment volumes and margins, foreign-exchange effects, commodity derivative results, and the recovery or persistence of Latin America currency impacts.
- Monitor the Superfund matter and multi-employer pension withdrawal exposure; the filing provides no clear estimate for potential Superfund remediation costs.